Piperacillin and Tazobactam precipitation or crystallization in IV bag or IV line upon reconstitution


Intravenous products: FDA report “Apotex Corp. notified healthcare professionals it is conducting, on behalf of the manufacturer Hospira, Inc., a voluntary nationwide recall of 15 lots of Piperacillin and Tazobactam for Injection, USP 40.5 grams, to the hospital/healthcare provider/user level. The impacted lots may show precipitation/ crystallization in IV bag or IV line after reconstitution. The product can also be identified by NDC number 60505-0773-00 and UPC 360505077304. The product was distributed nationwide in the United States to wholesalers, distributors, HMOs, home infusion and long term care service providers. See Press Release for a list of affected lot numbers.”

<a href=”http://feedburner.google.com/fb/a/mailverify?uri=Ivteam&amp;amp;loc=en_US&quot;”><img class=”alignnone” title=”IVTEAM email updates” src=”http://www.ivteam.com/ivteam-email-updates.gif” alt=”” /></a><a href=”http://www.ivteam.com”><img src=”http://www.ivteam.com/ivteam-main-iv-page.jpg” alt=”Main page” /></a>


Comments are closed.